Verastem Inc. (VSTM)
NASDAQ: VSTM
· Real-Time Price · USD
6.49
0.31 (5.02%)
At close: Jun 06, 2025, 3:03 PM
5.02% (1D)
| Bid | 6.48 |
| Market Cap | 356.62M |
| Revenue (ttm) | 24K |
| Net Income (ttm) | -148.88M |
| EPS (ttm) | -3.36 |
| PE Ratio (ttm) | -1.93 |
| Forward PE | -3.4 |
| Analyst | Buy |
| Ask | 6.5 |
| Volume | 1,161,883 |
| Avg. Volume (20D) | 1,580,079 |
| Open | 6.25 |
| Previous Close | 6.18 |
| Day's Range | 6.18 - 6.62 |
| 52-Week Range | 2.10 - 9.10 |
| Beta | 0.85 |
About VSTM
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol VSTM
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for VSTM stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts4 days ago
-19.95%
Verastem shares are trading lower. The company pro...
Unlock content with
Pro Subscription
2 weeks ago
-1.71%
Verastem Oncology shares are trading higher after the company announced phase 2 dose level 1 shows 83% overall response rate in frontline metastatic pancreatic ductal adenocarcinoma.
